Bharat Book introduces a report "Global Markets for Treatments for Syndromes of Dementia And Movement Disorders" which Coverage of approved human antifungal therapeutics with a heavy focus on therapeutics in early development.
Current and future characteristics of the global markets for treatments for syndromes of dementia and movement disorders.Comprehensive analysis of the market for genitourinary drugs on a global basis. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/2012-pharmaceuticals-research-review.html
The pharmaceutical manufacturing industry in 2012 saw a slew of mergers and acquisitions, many of which were years in the planning. Outside pressures have created this “eat or be eaten” mentality, and in many respects the merger and acquisition activity simply trades some short-term problems for some problems that need to be dealt with over a longer time span.
The market news has not been all bad as the overall pharmaceutical market grew to a historic trillion dollar high point. This stems from growing middle class consumption in the BRIC region (Brazil, Russia, India and China) and other regions.
BCC Research has provided comprehensive coverage of pharmaceutical markets for many years, and we are now increasing our coverage of this critically important global market. This review of pharmaceutical market research conducted by BCC Research in 2012 is meant to provide a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision-making since BCC was founded in 1971.
This review includes highlights from the following reports on pharmaceutical markets published BCC Research:
Antifungal Drugs: Technologies and Global Markets.
Global Markets for Treatments for Syndromes of Progressive Ataxia and Weakness.
Global Markets for Asthma and COPD Drugs.
Genitourinary Drugs: Technologies and Global Markets.
Global Markets for Treatments for Syndromes of Dementia And Movement Disorders.
Chapter- 1: FOREWORD - Complimentary 1 $0
Chapter- 2: GLOBAL MARKETS FOR TREATMENTS FOR SYNDROMES OF PROGRESSIVE ATAXIA AND WEAKNESS DISORDERS (REPORT PHM118A) 20 $150
PROGRESSIVE ATAXIA AND WEAKNESS DISORDERS
DIAGNOSTIC TESTS FOR PROGRESSIVE ATAXIA AND WEAKNESS DISORDERS
MARKETS BY DISORDERS
ADDITIONAL DRIVERS FOR PROGRESSIVE ATAXIA AND WEAKNESS DISORDERS DRUG MARKET
FACTORS GOVERNING THE MARKET
COLLABORATIONS, MERGERS AND ACQUISITIONS
Chapter- 3: ANTIFUNGAL DRUGS: TECHNOLOGIES AND GLOBAL MARKETS (REPORT PHM029D) 18 $205
HISTORY AND CURRENT STATE OF ANTIFUNGALS
TYPES OF PATHOGENIC FUNGI
DEFINITION OF THE INDUSTRY
IMPORTANCE OF THE INDUSTRY
PRODUCT LIFE CYCLES
DEVELOPMENT OF ANTIFUNGALS
ACTIVE OR COMPLETED STUDIES POSTED OR UPDATED, 2009 TO 2011
INTRODUCTION TO INDUSTRY APPLICATIONS OF ANTIFUNGAL MEDICINAL THERAPEUTICS
Chapter- 4: GLOBAL MARKETS FOR ASTHMA AND COPD DRUGS (REPORT PHM059B) 32 $364
DRUG DEVELOPMENT PROCESS
ACQUISITIONS AND MERGERS
Chapter- 5: GENITOURINARY DRUGS: TECHNOLOGIES AND GLOBAL MARKETS (REPORT PHM115A) 16 $182
DRUGS GOING OFF-PATENT IN FORECAST PERIOD
REVENUE PROJECTION FOR GENITOURINARY DRUGS, 2011-2016
TOP 10 BEST-SELLING GENITOURINARY DRUGS, 2011
REVENUE BY GENITOURINARY DISEASE DRUG SEGMENT
REVENUE FROM GENITOURINARY DRUGS BY GEOGRAPHIC AREA
MARKET SIZE AND FORECAST
Chapter- 6: GLOBAL MARKETS FOR TREATMENTS FOR SYNDROMES OF DEMENTIA AND MOVEMENT DISORDERS (REPORT PHM117A) 25 $285
CLASSIFICATION OF NEURODEGENERATIVE DISORDERS
DIAGNOSTIC TESTS FOR NEURODEGENERATIVE DISORDERS
OVERALL DRIVERS OF THE MARKET FOR TREATMENTS FOR SYNDROMES OF DEMENTIA AND MOVEMENT DISORDERS
OTHER FACTORS AFFECTING THE MARKET
COLLABORATIONS/MERGERS AND ACQUISITIONS
List of Tables
Table 1 : GLOBAL MARKET FOR PROGRESSIVE ATAXIA AND WEAKNESS DISORDERS, THROUGH 2017
Table 2 : CLASSIFICATION BY PRIMARY DYSFUNCTION
Table 3 : GLOBAL REVENUES OF DRUG PRODUCTS FOR THE TREATMENT OF NEURODEGENERATIVE DYSFUNCTIONS, THROUGH 2017
Table 4 : MARKET SHARE OF DRUGS USED FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS BY DYSFUNCTIONS, 2011
Table 5 : GLOBAL MARKET FORECAST FOR HUMAN ANTIFUNGAL THERAPEUTICS BY GEOGRAPHIC REGION, THROUGH 2016
Table 6 : DRUG DEVELOPMENT LIFECYCLE FOLLOWING DISCOVERY OF NEW DRUG
Table 7 : CLINICAL TRIALS OF ALL NEW DRUG THERAPIES AND COMBINATIONS BY ALL DATE FIELDS, 2009–2011
Table 8 : SELECTED GLOBAL CLINICAL TRIALS OF ALL NEW DRUG THERAPIES THAT EITHER ARE COMPLETED OR ESTIMATED TO BE COMPLETED BETWEEN 2009 AND 2012
Table 9 : ACTIVE OR COMPLETED STUDIES, 2009–2011
For more information kindly visit : http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/2012-pharmaceuticals-research-review.html
Contact us at :
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Follow us on twitter: https://twitter.com/researchbook
Follow us on Linkedin : http://www.linkedin.com/company/bharat-book-bureau
Our Blog : http://blog.bharatbook.com/
Global Markets for Treatments for Syndromes of Dementia And